Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know?
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0097
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Molecular Pathology of Poorly Differentiated and Anaplastic Thyroid Cancer: What Do Pathologists Need to Know? ; volume:32 ; number:1 ; day:4 ; month:2 ; year:2021 ; pages:63-76 ; date:3.2021
Endocrine pathology ; 32, Heft 1 (4.2.2021), 63-76, 3.2021
- Creator
-
Volante, Marco
Lam, Alfred K.
Papotti, Mauro
Tallini, Giovanni
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s12022-021-09665-2
- URN
-
urn:nbn:de:101:1-2021050212405677205293
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:54 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Volante, Marco
- Lam, Alfred K.
- Papotti, Mauro
- Tallini, Giovanni
- SpringerLink (Online service)
Other Objects (12)
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Genetic profiling of poorly differentiated sinonasal tumours
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Poorly differentiated carcinoma arising from adenolymphoma of the parotid gland
Poorly differentiated component in gastric pinch biopsies predicts submucosal invasion
Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)
Characterization of the genomic alterations in poorly differentiated thyroid cancer
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Genetic profiling of poorly differentiated sinonasal tumours
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Poorly differentiated carcinoma arising from adenolymphoma of the parotid gland
Poorly differentiated component in gastric pinch biopsies predicts submucosal invasion
Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)
Characterization of the genomic alterations in poorly differentiated thyroid cancer
Combination of Lenvatinib and Pembrolizumab is an effective treatment option for anaplastic and poorly differentiated thyroid carcinoma
Combination of Lenvatinib and Pembrolizumab Is an Effective Treatment Option for Anaplastic and Poorly Differentiated Thyroid Carcinoma
FGF-Receptors and PD-L1 in Anaplastic and Poorly Differentiated Thyroid Cancer: Evaluation of the Preclinical Rationale
FGF-receptors and PD-L1 in anaplastic and poorly differentiated thyroid cancer: evaluation of the preclinical rationale
Contrast-enhanced CT-based Radiomics for the Differentiation of Anaplastic or Poorly Differentiated Thyroid Carcinoma from Differentiated Thyroid Carcinoma: A Pilot Study
Poorly differentiated thyroid carcinoma : An underdiagnosed entity
Genetic profiling of poorly differentiated sinonasal tumours
MRI features of histological subtypes of thyroid cancer in comparison with CT findings: differentiation between anaplastic, poorly differentiated, and papillary thyroid carcinoma
Poorly differentiated carcinoma arising from adenolymphoma of the parotid gland
Poorly differentiated component in gastric pinch biopsies predicts submucosal invasion
Poorly Differentiated Carcinomas of the Foregut (Gastric, Duodenal and Pancreatic)